Patient voices in pharmacovigilance takes centre stage at ISoP Bali 2023

Communications / 16 January 2024

The most recent ISoP event saw hundreds of experts gather to explore the latest innovations and challenges facing pharmacovigilance, with a special focus on patient perspectives.

Last November, Bali became a pivotal stage for the 22nd annual meeting of the International Society of Pharmacovigilance (ISoP), an event that brought to the fore critical discussions and innovations in the field of medicine safety. The meeting drew a global audience of 315 participants from 49 different countries, emphasising the importance of diverse perspectives in pharmacovigilance from the Global South.

The pre-conference events alone attracted over 100 attendees, including experts from Indonesian and Australian regulatory bodies. Sessions focused on key pharmacovigilance topics: fundamental principles, the safety of herbal and traditional medicines, and the integration of pharmacovigilance into healthcare systems. The overall aim of these events was to strengthen the pharmacovigilance framework by taking the perspective of the patient into account.

The conference began with a vibrant Indonesian ceremony and an address by the Interim Head of Indonesia's National Drug and Food Agency. The first day's sessions emphasised patient safety in global pharmacovigilance and the importance of patient involvement in decisions regarding medicine safety. Patients and support groups shared their perspectives on the topic, enhancing the session's overall impact.

The parallel sessions offered in-depth explorations into various pharmacovigilance topics. These included insights from Southeast Asia and the Western Pacific, discussions on ecopharmacovigilance, and considerations for older populations' medication safety. The conference also shed light on the environmental impacts of medications and the nuanced aspects of vaccine pharmacovigilance, with a specific focus on COVID-19 vaccines.


The second day focused on effective communication strategies in medication safety. A plenary session tackled the challenge of translating scientific information accurately for media consumption, emphasising the need for clear communication policies in pharmacovigilance.

Further parallel sessions delved into the safety of medicines for women and their professional development in pharmacovigilance. These discussions addressed global perspectives on access to and safety issues surrounding contraceptive medicines and devices, calling for a nuanced approach to medicine safety across different demographic groups.

The final day highlighted areas such as medical devices and the clinical aspects of pharmacovigilance. The plenary session, featuring the Bengt Erik Wiholm Lecture by Shanthi Pal from the World Health Organisation, focused on the efficacy of spontaneous reporting systems in low and middle-income countries.

As always, ISoP conferences foster networking and mentorship, exemplified by a student-focused event that encouraged connections among upcoming pharmacovigilance experts, reflecting ISoP's dedication to developing new talent. It also provides a forum for ISoP members to be part of the organisation’s strategic dialogue and receive specific ISoP chapter updates. The event concluded with an announcement for next year’s annual conference in Montreal, Canada, as well as a poster prize ceremony, which honoured outstanding pharmacovigilance research underscoring the global progress in the field.

Grace Wangge @gwangge
A/Prof in Public Health, Monash University, Indonesia, Chair of LoC 22nd ISoP Annual Conference Monash University, Indonesia/ISoP Indonesia Chapter

You may also like

Fifty years of putting medicines and vaccine safety at the heart of global healthcare

The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.

Communications / 11 March 2024

Patient safety set to gain from new partnership between CDISC and UMC

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

Communications / 20 February 2024

Catching Black swans – New podcast out now

We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.

Communications / 04 March 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more